Jeremy Fricke

10PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer geneticsDecision support and group support systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 27, 2025
Current Clinical Paradigm and Therapeutic Advancements in Thymic Malignancies: A Narrative Review.

Douglas Dias E Silva, Beatriz Viesser Miyamura, Isa Mambetsariev

|Oct 28, 2025
Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition.

Adam Rock, Isa Mambetsariev, Siddhika Pareek

|Mar 21, 2025
Novel LZTR1 germline mutation as a mechanism of resistance to osimertinib in EGFR-mutated lung adenocarcinoma: a case report.

Wai Park, Jeremy Fricke, Isa Mambetsariev

|Jul 14, 2023
Clinical Network Systems Biology: Traversing the Cancer Multiverse.

Isa Mambetsariev, Jeremy Fricke, Stephen B Gruber

|Mar 11, 2023
A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine.

Martin Sattler, Isa Mambetsariev, Jeremy Fricke

Pageof 2